Mesa Laboratories, Inc.MLABNASDAQ
Loading
MLAB Revenue Growth (YoY Quarterly)•+3.64%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
+3.64%
-1.4pp
+5.13%
-0.2pp
+30.27%
+47.2pp
+38.00%
+3.3pp
+0.00%
+27.8pp
+0.00%
+28.6pp
+0.00%
+28.6pp
+1.90%
+0.1pp
+2.51%
+1.3pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +17.52% | +5.49% | +2.36% | +5.02% | +3.64% |
| Gross Profit Growth | +19.02% | +5.08% | -12.77% | +5.29% | +5.13% |
| EBITDA Growth | -52.36% | +0.00% | +24.20% | -16.96% | +30.27% |
| Operating Income Growth | +0.00% | +0.00% | -45.09% | +34.66% | +38.00% |
| Net Income Growth | -179.21% | +0.00% | +39.96% | -27.77% | +0.00% |
| EPS Growth | -179.49% | +0.00% | +38.10% | -28.57% | +0.00% |
| EPS Diluted Growth | -179.49% | +0.00% | +37.10% | -28.57% | +0.00% |
| Weighted Average Shares Growth | +0.67% | +0.65% | +1.26% | +1.83% | +1.90% |
| Weighted Average Shares Diluted Growth | +0.61% | +0.65% | +2.38% | +1.17% | +2.51% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +59.85% | -1.69% | -81.86% | +55.99% | +1.71% |
| Free Cash Flow Growth | +69.37% | -5.59% | -90.74% | +104.71% | +2.25% |
| Receivables Growth | +7.28% | +7.46% | +9.84% | -0.35% | +4.10% |
| Inventory Growth | -21.82% | -22.37% | -11.52% | -6.72% | -5.56% |
| Asset Growth | -41.07% | -3.01% | -1.05% | -5.23% | -0.53% |
| Book Value per Share Growth | -61.74% | +9.22% | +13.02% | +8.55% | +18.04% |
| Debt Growth | -10.37% | -19.23% | -10.79% | -19.83% | -51.13% |
| R&D Expense Growth | +17.68% | -2.04% | +5.26% | +8.93% | -0.47% |
| SG&A Expenses Growth | -0.87% | +13.31% | +7.27% | +0.90% | -0.45% |
1 / 4